Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
New nanoparticle therapy offers potential new treatment for aggressive breast cancer
Researchers at the University of Maryland School of Medicine, USA, (UMSOM) developed a new nanoparticle…
Skin cancer suppressor found
A promising route to develop new treatments for skin cancer has been identified by University…
A solid vaccine for liquid tumours
Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow…
Decision-Making in the Midst of Medical Un/Certainty
By Gayle A. Sulik MA, Ph.D. Evidence and controversy over Contralateral Prophylactic Mastectomy (CPM) A recent string of articles in…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.